Truist Securities Rates National Health Investors (NHI) buy
Truist Securities has reaffirmed its buy rating on National Health Investors with a target price of $81, a 13.97% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Truist Securities rated National Health Investors, Inc. ($NHI) "buy" with a $81 price target on June 12, 2026.
Since the rating, $NHI is down 1.6% after 1 week, up 6.5% after 1 month and down 5.6% to date (from the $70.24 close on Jun 12, 2026).
NHI
National Health Investors, Inc.
Key Points
- Truist Securities reiterated its buy rating on National Health Investors, targeting $81 while the stock trades at $71.07.
- Truist Securities's $81 price target implies 13.97% upside from National Health Investors, Inc.'s ($NHI) current $71.07 share price.
- The stock is currently priced below the target, suggesting potential for growth in the coming months.
- National Health Investors has a P/E ratio of approximately 19.6, indicating a solid valuation relative to its earnings.
Get $NHI trade alerts by text
We text you when insiders, Congress or big funds trade $NHI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated National Health Investors, Inc. alert may contain errors. Disclosures
Truist Maintains Buy Rating on NHI
On June 12, 2026, Truist Securities reiterated its buy rating on National Health Investors, Inc. (NYSE: NHI) with a price target of $81. The stock closed at $71.07, indicating a gap of about 13% to the target price, which suggests room for potential growth.
What Changed in the Position
Truist's action does not reflect a change in its position but reaffirms its confidence in the stock. The target price remains unchanged, while the stock trades lower than its previous close of $67.80.
Analysts Set New Price Targets
Other analysts have also weighed in on National Health Investors. On September 2, 2026, Truist maintained its buy rating with a target of $80, while Wells Fargo kept an equal-weight rating with a target of $78 on September 1. Deutsche Bank maintained a hold rating with a target of $80 on June 25. This mix of ratings shows a general consensus of cautious optimism about the stock's performance.
How National Health Investors, Inc. Stock Has Traded
National Health Investors has seen its stock price fluctuate recently. The shares are currently trading below their 50-day moving average of about $73.93. Investors may find this concerning, especially since the stock is also below its 52-week high of $91.38. However, the current price offers a potential entry point for those looking to invest.
$NHI price target
National Health Investors, Inc. daily closes and this analyst's $81 target. Not advice.
Recent Earnings
In its latest earnings report, National Health Investors reported revenue of approximately $435.8 million, reflecting a growth rate of about 33.8%. The next earnings report is scheduled for November 5, 2026, which could provide further insights into the company's financial health.
What National Health Investors, Inc. Does
National Health Investors, Inc. is a self-managed real estate investment trust (REIT) based in Murfreesboro, Tennessee. The company focuses on owning and managing high-quality real estate properties, particularly in the senior housing and healthcare sectors. This focus on essential services underscores the importance of its performance in the current market.
What's Ahead for National Health Investors, Inc.
As National Health Investors prepares for its upcoming earnings report in November, investors will be watching closely to see how the company performs. Truist's reiteration of its buy rating, combined with the current stock price, indicates a belief in the company's ability to grow and recover in the coming months.
Related Filing Alerts
Source: Truist Securities's rating change on $NHI (Jun 12, 2026). Written by software, not financial advice. How we make alerts